IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma
Corresponding Author
Axel zur Hausen
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Fax: ++49-221-478-6360
Institute of Pathology, University Hospital Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, GermanySearch for more papers by this authorJ. Bart A. Crusius
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorLaura S. Murillo
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorBehrooz Z. Alizadeh
Genetic Epidemiology Unit, Departments of Epidemiology and Biostatistics and Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands
Search for more papers by this authorServaas A. Morré
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorChris J.L.M. Meijer
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorAdriaan J.C. van den Brule
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorAmado Salvador Peña
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorCorresponding Author
Axel zur Hausen
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Fax: ++49-221-478-6360
Institute of Pathology, University Hospital Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, GermanySearch for more papers by this authorJ. Bart A. Crusius
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorLaura S. Murillo
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorBehrooz Z. Alizadeh
Genetic Epidemiology Unit, Departments of Epidemiology and Biostatistics and Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands
Search for more papers by this authorServaas A. Morré
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorChris J.L.M. Meijer
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorAdriaan J.C. van den Brule
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorAmado Salvador Peña
Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this author
REFERENCES
- 1 El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398–402 [correction appeared in Nature 2001;412:99].
- 2 Machado JC, Pharaoh P, Sousa S, Carvalho R, Oliviera C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M. Interleukin 1B and Interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823–9.
- 3 IARC. Schistosomes, liver flukes and Helicobacter pylori. vol. 61. Lyon: IARC, 1994. 177–240.
- 4 Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992; 140: 769–74.
- 5 Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994; 91: 9131–5.
- 6
Nakamura S,
Ueki T,
Yao T,
Ueyama T,
Tsuneyoshi M.
Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis.
Cancer
1994;
73:
2239–49.
10.1002/1097-0142(19940501)73:9<2239::AID-CNCR2820730902>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 7 Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53: 255–61.
- 8 Zur Hausen A, van Grieken NCT, Meijer GA, Hermsen MAJA, Bloemena E, Meuwissen SGM, Baak JPA, Meijer CJLM, Kuipers EJ, van den Brule AJC. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 2001; 121: 612–8.
- 9 Zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJLM, van den Brule AJC. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000; 60: 2745–8.
- 10 Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT. Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 2002; 185: 106–9.
- 11 Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, et al. 2002. Interleukin-1β expression in human gastric carcinoma with Epstein-Barr Virus infection. J Virol 2002; 76: 6825–31.
- 12 Huang YT, Sheen TS, Chen CL, Lu J, Chang Y, Chen JY, Tsai CH. Profiles of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res 1999; 59: 1599–605.
Citing Literature
